Latest

Related Posts

Health News Roundup: U.S. to boost monkeypox vaccine supply with 1.8 million extra doses; Germany’s constitutional court upholds measles vaccine mandate for children and more

Following is a summary of current health news briefs. U.S. to boost monkeypox vaccine supply with 1.8 million extra doses The United States said on Thursday it will boost its supply of monkeypox vaccine by making available an extra 1.8 million doses of Bavarian Nordic’s Jynneos shot, as the number of reported cases in the […]

- Advertisement -

Following is a summary of current health news briefs.

- Advertisement -

U.S. to boost monkeypox vaccine supply with 1.8 million extra doses

The United States said on Thursday it will boost its supply of monkeypox vaccine by making available an extra 1.8 million doses of Bavarian Nordic’s Jynneos shot, as the number of reported cases in the country rose above 13,500. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), gave the figure for reported cases as of Aug.17, which represent more than a third of the global total of 39,000, at a White House briefing.

Germany’s constitutional court upholds measles vaccine mandate for children

The German constitutional court upheld the country’s measles vaccine mandate for children on Thursday, ruling against a challenge brought by parents. In its final decision on the matter, the court in Karlsruhe said that while the mandate interfered with the rights of children and their parents, this was justified due to the high infection risk with measles and the potential for serious illness.

Bavarian Nordic signs up U.S. firm for packaging monkeypox vaccine

Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manufacturer to package its Jynneos monkeypox vaccine and the production is expected to begin later this year. The company aims to finish the technology transfer in three months to Michigan-based Grand River Aseptic.

N.Korea’s Kim praises military medics for frontline COVID fight in the capital

North Korean leader Kim Jong Un held a ceremony to thank and praise military medics for spearheading the country’s fight against the coronavirus in the capital Pyongyang, state media said on Friday. Thousands of medics of the Korean People’s Army, who had been dispatched to the “emergency anti-epidemic front”, were discharged after Kim declared victory over COVID-19 and eased restrictions last week.

WHO recommends Valneva’s COVID vaccine?

The World Health Organization (WHO) on Thursday recommended the use of French drugmaker Valneva’s COVID-19 vaccine. The UN agency also recommended the use of a second booster dose for some individuals at high risk of severe disease.

Bluebird falls on worries over $2.8 million gene therapy’s commercial success

Bluebird bio slumped nearly 15% on Thursday as investors fretted over the sales potential of its newly approved ultra-rare blood disorder gene therapy which is the most expensive treatment to date at $2.8 million. The one-time treatment, Zynteglo, was approved by the U.S. Food and Drug Administration on Wednesday for patients with beta-thalassemia requiring regular blood transfusions. There are about only 1,500 of them in the United States.

Abortion drug maker drops challenge to Mississippi ban

A manufacturer of the drug used in medication abortions on Thursday dropped its bid to sell mifepristone in Mississippi despite the state’s recently enacted abortion ban. GenBioPro Inc said it was voluntarily dismissing its case in a filing in federal court in Jackson. The company had argued that federal regulators’ approval of mifepristone to induce abortion at up to 10 weeks of pregnancy overrode the state’s prohibition on nearly all abortions.

Valneva: U.S. Dept of Defense ends Ixiaro vaccine supply deal

The U.S. Department of Defense (DoD) has ended an encephalitis vaccine supply contract with Valneva, said the French drugmaker, adding that a slowdown in global travel activity, mainly affecting Asia, had led to lower demand. The development, which Valneva said had no impact on this year’s financial guidance, dragged down the company’s shares in early session trading by around 1%.

Factbox: Monkeypox cases and deaths around the world

More than 80 countries where monkeypox is not endemic have reported outbreaks of the viral disease, which the World Health Organization has declared a global health emergency, as confirmed cases crossed 38,800 and non-endemic countries reported their first related deaths. Below are the non-endemic countries that have reported monkeypox-related deaths:

John Hancock in $26.3 million settlement with New York over canceled insurance policies

John Hancock Life & Health Insurance Co will pay $26.3 million to settle a New York probe that found it prematurely terminated long-term care policies before policyholders, many now dead, exhausted their benefits. New York’s Department of Financial Services on Thursday said Hancock, a unit of Canada’s Manulife Financial Corp, improperly ended 156 insurance policies early between 2001 and 2019.

(With inputs from agencies.)

Popular Articles

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Accept
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active
PRIVACY POLICY
  1. General
  • (1.1.) Eduvast (“Eduvast”, “We”, “Our”, “Us”) is committed to the protection of personal information provided by the users (“You”,“Your”,“User”) to Eduvast. You agree that Your use of Eduvast implies Your consent to the collection, retention and use of Your personal information in accordance with the terms of this Privacy Policy (“Privacy Policy”).
  • (1.2.) We take the privacy of our Users seriously. We are committed to safeguarding the privacy of Users while providing personalized and valuable service.
  • (1.3.) While We do Our best to protect Your information, particularly with respect to the protection of Your personal data, Eduvast cannot ensure the security of Your data transmitted via the internet, telephone or any other networks.
  • (1.4.) Access to the contents available  is conditional upon Your acceptance of this Privacy Policy which should be read together with the End User License Agreement“EULA”.
  • (1.5.) If You do not agree to any of the provisions of this Privacy Policy or EULA, You should not download, install and use the App. We may revise, alter, add, amend or modify this Privacy Policy at any time by updating this privacy policy. By downloading, installing and/or using this App, You agree to be bound by any such alteration, amendment, addition or modification.
2. Information Collected Non Personal Information
  • (2.1.) We may collect non-personal information about You whenever You access or interact with Our Website or any of the related services. This includes but not limited to browser name, version, server location, device specific information such as the type of device used, users’ operating system and version, your mobile devices unique device ID, third party apps or App or service that referred users to App, language preference, means of connection to App, internet service providers, IP address, technical information, google advertising ID (GAID), IDFA, GAID Opt-out Status, location information, interaction of Your device with the App and applications, details of Your device including without limitation its manufacturer details, height and width of your device screen, model, version, UDID or IMEI Number and other similar information about You(collectively "Traffic Data”). Personal Information
  • (2.2.) 2.2. We may collect personal information that identifies You in a variety of ways, including, but not limited to the information submitted during download and installation of the App or in connection with registration for other activities or features offered through the App. Personally identifiable information collected may include name, mailing address, email address, phone number and demographic information such as gender, nationality, postcode and other personal information including but not limited to date, time or place of birth ("Personal Information"). If You communicate with Us by, for example, e-mail or letter, any information provided in such communication may be collected by Eduvast.
  • (2.3.) Our website may transmit your Personal Information to our internal servers. This Personal Information is immediately deleted once you delete the App, except to the extent it is necessary to store the same under applicable laws. Further, we have implemented commercially reasonable physical, managerial, operational and technical security measures to protect the loss, misuse and alteration and to preserve the security of the Personal Information in our care.Finally, this information is used strictly in line with our business purposes.
  • (2.4.) You understand that once You leave Our servers, use of any information You provide shall be governed by the privacy policy of the operator of the site used by You.
3. Disclosure of Personal Information
    • (3.1.) We do not disclose Your Personal Information to any third parties other than as may be required by us, Eduvast’s affiliates, partners, trusted business networks, in compliance with our Privacy Policy for the purpose of moderating the content of the Website, enhancing Your user experience, providing You localised content and to enable Us and Our partners to provide You with targeted information which may be of benefit to you.
    • (3.2.) To enhance customer experience and to provide focused support, we may share generic aggregated demographic information which may include Your information collected by Us but not linked to any personally identifiable information regarding visitors and users with Our business partners, trusted affiliates and advertisers for the purposes outlined above.
    • (3.3.) At times We are required by law or litigation to disclose personal information about the users. We may also disclose information about the user if We determine that disclosure of information is necessary for national security, law enforcement, or other issues of public importance.
    • (3.4.) We use Our best efforts to use information in aggregate form (so that no individual User is identified) for the following purposes:
(3.4.1) To build up marketing profiles; (3.4.2) To aid strategic development, data collection and business analytics; (3.4.3) To manage our relationship with advertisers and partners; (3.4.4) 3.4.4. To audit usage of Our website i.e. www.www.eduvast.com (3.4.5) 3.4.5. To enhance user experience in relation to the App and Our website (collectively, “Permitted Use”).
  • (3.5.) We reserve the right to disclose Personal Information if required to do so by law or if we believe that it is necessary to do so to protect and defend the rights, property or personal safety of Eduvast, the App, or Users.
4. Cookies
  • (4.1.) Whenever You access the App We may place "cookies" on Your hard drive for record-keeping purposes to enhance Your experience or sometimes to personalize Your experience. Cookies are small text files that are placed on Your device's hard drive by the App You visit. Cookies help Us to identify information relating Your activities and to retain information relating to Your preferences and history on the App.
  • (4.2.) Ad targeting cookies: We and/or Our service providers may use advertising cookies to deliver ads that are more relevant to You and Your interests.
  • (4.3.) You may choose to disable cookies by turning off cookie feature on the web browser. However, by disabling this feature, some parts of the App may not function properly. This may prevent You from taking full advantage of the App.
5. Confidentiality
    • (5.1.) Except as otherwise provided in this Privacy Policy, We will keep Your Personal Information private and will not share it with third parties, unless We believe in good faith that disclosure of Your Personal Information or any other information We collect about You is necessary for Permitted Use or to:
(5.1.1.) Comply with a court order or other legal process; (5.1.2.) Protect the rights, property or safety of Eduvast or another party; (5.1.3.) Enforce the Agreement, including EULA; or (5.1.4.) Respond to claims that any posting or other content violates the rights of third-parties. 6. Security
  • (6.1.) The security of Your Personal Information is important to Us. We follow generally accepted industry standards to protect the Personal Information submitted to Us, both during transmission and once We receive it.
  • (6.2.) Although We make best possible efforts to store Personal Information in a secure operating environment which is not open to the public, You should understand that there is no such thing as complete security, and We do not guarantee that there will be no unintended disclosures of Your Personal Information. If We become aware that Your Personal Information has been disclosed in a manner not in accordance with this Privacy Policy, We will use reasonable efforts to notify You of the nature and extent of such disclosure (to the extent We know that information) as soon as reasonably possible and as permitted by law.
7. Updates and Changes to Privacy Policy
  • We reserve the right, at any time, to add to, change, update, or modify this Privacy Policy so please review it frequently. In all cases, use of information We collect is subject to the Privacy Policy in effect at the time such information is collected. You hereby acknowledge and agree that it is Your responsibility to review this Privacy Policy periodically and become aware of the modifications. If You disagree to any of the changes to the Privacy Policy, You shall refrain from using or accessing the App. Your continued use of the App following the posting of the revised Policy shall indicate Your acceptance and acknowledgment of the changes and You will be bound by it.
8. Updates and Changes to Your Personal Information
  • You have a right to correct any errors in Your Personal Information available with Us. You may request Us in writing that We cease to use Your Personal Information.
9. Contact Us
  • You may write to us at [email protected] for any privacy concerns and requests relating to this EULA and Privacy Policy.
Save settings
Cookies settings